Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2017 / Cilt: 25 - Sayı: 2

Long-term outcomes and prognostic factors of pulmonary metastasectomy in breast cancer patients: a systematic review

Meme kanseri hastalarında pulmoner metastazektominin uzun dönem sonuçları ve prognostik faktörleri: Sistematik derleme

Pages
319–323
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to our study results, disease-free interval, hormone receptor status, number of metastases, width of metastatic resection and size of metastases, in a descending order, are important prognostic factors for pulmonary metastasectomy in patients with breast cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Breast cancer is the leading cause of cancer-related deaths in women in developing countries.
📊
Key Findings & Data:All studies regarding the outcomes and prognostic factors of pulmonary metastasectomy in patients with breast cancer between April 1990 and April 2016 were included in this review.
💡
Conclusion & Impact:According to our study results, disease-free interval, hormone receptor status, number of metastases, width of metastatic resection and size of metastases, in a descending order, are important prognostic factors for pulmonary metastasectomy in patients with breast cancer.
🔬Design:Review & Systematic Survey
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Breast cancer is the leading cause of cancer-related deaths in women in developing countries. The aim of this systematic review was to evaluate long-term outcomes and prognostic factors of pulmonary metastasectomy in patients with breast cancer. A comprehensive search was performed in the MEDLINE, Web of Science, and Scopus databases using selected keywords. All studies regarding the outcomes and prognostic factors of pulmonary metastasectomy in patients with breast cancer between April 1990 and April 2016 were included in this review. Disease-free interval was identified as a prognostic factor in 10, size of metastasis in three, number of metastases and width of resection in five, and hormone receptor status in six studies. According to our study results, disease-free interval, hormone receptor status, number of metastases, width of metastatic resection and size of metastases, in a descending order, are important prognostic factors for pulmonary metastasectomy in patients with breast cancer.

Özet

Meme kanseri, gelişmekte olan ülkelerde kadınlarda kansere bağlı ölümlerin başlıca nedenidir. Bu sistematik derlemede, meme kanserli hastalarda akciğer metastazektomisinin uzun dönem sonuçları ve prognostik faktörleri değerlendirildi. MEDLINE, Web of Science ve Scopus veri tabanlarında belirli anahtar sözcükler kullanılarak kapsamlı bir tarama yapıldı. Bu derlemeye Nisan 1990 - Nisan 2016 tarihleri arasında meme kanserli hastalarda pulmoner metastazektominin sonuçları ve prognostik faktörlerine ilişkin çalışmaların tümü dahil edildi. Çalışmaların 10’unda hastalıksız geçen süre, üçünde metastaz bölgesi, beşinde metastaz sayısı ve rezeksiyon genişliği ve altısında hormon reseptör statüsünün prognostik faktör olduğu belirlendi. Çalışma sonuçlarımıza göre, sırasıyla hastalıksız geçen süre, hormon reseptör statüsü, metastaz sayısı, metastatik rezeksiyon genişliği ve metastaz bölgesi meme kanserli hastalarda pulmoner metastazektominin önemli prognostik faktörleridir.

🔖

Cite This Article

SOURATİ, A., MOGHANİ, M. M., AZGHANDİ, S. (2022). Long-term outcomes and prognostic factors of pulmonary metastasectomy in breast cancer patients: a systematic review. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 25 - Sayı: 2, 319–323. https://ajindex.com/articles/423956

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Yamamoto N, Katsumata N, Watanabe T, Omuro Y, Ando M, Narabayashi M, et al. Clinical characteristics of patients with metastatic breast cancer with complete remission following systemic treatment. Jpn J Clin Oncol 1998
  2. Fan J, Chen D, Du H, Shen C, Che G. Prognostic factors for resection of isolated pulmonary metastases in breast cancer patients: a systematic review and meta-analysis. J Thorac Dis 2015
  3. Mimoto R, Kobayashi T, Imawari Y, Kamio M, Kato K, Nogi H, et al. Clinical relevance and low tumor-initiating properties of oligometastatic breast cancer in pulmonary metastasectomy. Breast Cancer Res Treat 2014
  4. Meimarakis G, Rüttinger D, Stemmler J, Crispin A, Weidenhagen R, Angele M, et al. Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer. Ann Thorac Surg 2013
  5. Kycler W, Laski P. Surgical approach to pulmonary metastases from breast cancer. Breast J 2012
  6. Yhim HY, Han SW, Oh DY, Han W, Im SA, Kim TY, et al. Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy. Cancer 2010
  7. Chen F, Fujinaga T, Sato K, Sonobe M, Shoji T, Sakai H, et al. Clinical features of surgical resection for pulmonary metastasis from breast cancer. Eur J Surg Oncol 2009
  8. Yoshimoto M, Tada K, Nishimura S, Makita M, Iwase T, Kasumi F, et al. Favourable long-term results after surgical removal of lung metastases of breast cancer. Breast Cancer Res Treat 2008
  9. Welter S, Jacobs J, Krbek T, Tötsch M, Stamatis G. Pulmonary metastases of breast cancer. When is resection indicated? Eur J Cardiothorac Surg 2008
  10. Planchard D, Soria JC, Michiels S, Grunenwald D, Validire P, Caliandro R, et al. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma. Cancer 2004
  11. Ludwig C, Stoelben E, Hasse J. Disease-free survival after resection of lung metastases in patients with breast cancer. Eur J Surg Oncol 2003
  12. Simpson R, Kennedy C, Carmalt H, McCaughan B, Gillett D. Pulmonary resection for metastatic breast cancer. Aust N Z J Surg 1997
  13. Livartowski A, Chapelier A, Beuzedoc P, Dierick A, Asselain B, Dartevelle P, et al. Surgery of lung metastases of breast cancer: analysis of 40 cases Bull Cancer 1998
  14. Friedel G, Linder A, Toomes H. The significance of pro